The biomarker assay can be used potentially to enrich clinical trials and monitor patients' disease activity and treatment response.

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

Heather James, 66, revealed she was 'naive' about her daughter's cancer diagnosis and thought she would be 'fine' after six ...

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

We spoke to experts about how spicy food affects the body, whether it's healthy, and the potential benefits and risks to know ...

It may seem counter-intuitive, but losing weight without even trying may not be a good thing."It's not typical to hav ...

All Blacks v Ireland: New Zealand anthem bizarrely cut short in Dublin The King acknowledges his ‘advancing years’ ahead of ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Recent research has been pointing to the gut as ground zero for mental and physical wellness. Local health professionals weigh in.

Number 5: By expanding educational initiatives to clarify biosimilar safety, efficacy, and interchangeability, stakeholders can foster trust, improve access, and ensure that biosimilars are widely ...